RNF182 and Alzheimer disease: It was found that ATP6V0C is a substrate of RNF182; the up-regulation of RNF182 in AD brain can be mediated by the proteasomal degradation pathway to promote ATP6V0C degradation, which ultimately leads to neuronal apoptosis and accelerates AD pathology (Okamoto et al., 2020).